TGFB1 and Hepatic fibrosis: Similarly, novel drug delivery systems, such as CXCR4-targeted liposomes that combine pirfenidone with AMD3100, exhibited enhanced antifibrotic effects in liver fibrosis models by modulating TGF-β, α-SMA, and collagen I expression [66].